Phenotypic screening in the 21st century

In the genomic era of 1990s-2000s, pharmaceutical research moved to target-based drug discovery which enabled development of a number of small molecule drugs against a wide range of diseases. In many cases however, drugs that arose from genomics failed, questioning the validity of the targets and th...

Full description

Autores:
Tipo de recurso:
Book
Fecha de publicación:
2015
Institución:
Universidad de Bogotá Jorge Tadeo Lozano
Repositorio:
Expeditio: repositorio UTadeo
Idioma:
eng
OAI Identifier:
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14277
Acceso en línea:
https://www.frontiersin.org/research-topics/1725/phenotypic-screening-in-the-21st-century
http://hdl.handle.net/20.500.12010/14277
Palabra clave:
Therapeutics
Science (General)
Label-free technologies
Phenotypic screenning
Target-based assays
Systems Biology
Pathways
Drug Discovery
Panomic data
Gene networks ---
Rights
License
Abierto (Texto Completo)